These observations have also been observed in humans, manifesting as impaired flow-induced vasodilation in hypercholesterolemic patients, thus suggesting cholesterol-induced suppression of Kir2.1 as a mechanism underlying endothelial dysfunction in this pathology (162). The gene discussed is KCNJ2; the disease is endothelial dysfunction.